Dynorphin A vs Endomorphin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Dynorphin A is a 17-amino acid endogenous opioid peptide cleaved from prodynorphin, the precursor protein also giving rise to dynorphin B and alpha/beta-neoendorphin. Dynorphin A is the primary endogenous agonist of kappa-opioid receptors (KOR) and one of the most potent endogeno...
Calculate Dynorphin A dose →Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) and Endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) are tetrapeptides discovered in 1997 by Zadina et al. as the most selective and potent endogenous agonists of the mu-opioid receptor (MOR)....
Calculate Endomorphin dose →| Parameter | Dynorphin A | Endomorphin |
|---|---|---|
| Category | Endogenous Opioid | Endogenous Opioid |
| Research | Research | Research |
| Half-Life | Short (minutes) | Seconds to minutes (rapidly degraded) |
| Typical Dose | 1-10 nmol (central, animal) | 1-100 nmol/kg (animal) |
| Frequency | Variable | Variable |
| Route | Intrathecal, Intracerebroventricular (research) | Intrathecal, Intracerebroventricular, Subcutaneous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.